The global automated endoscopy reprocessor market size was valued at US$ 845.3 million in 2017 and is expected to witness a robust CAGR of 6.7% over the forecast period (2018–2026).

Mergers and acquisitions by market players are expected to drive the neurodegenerative disease treatment market growth.

Strategic collaboration to develop advance smart card technology to provide value added services in healthcare is expected propel growth of the market.

Increasing number of awareness campaigns for weight management is expected to be a major driver for Orlistat market growth

Increasing number of samples to be analyzed is increasing the demand for faster analytical methods that are capable of providing better information for decision making.

Drug resistance to antifungal medications is widely witnessed during treatment of aspergillosis infections, which is expected to restrain growth of the acute invasive aspergillosis treatment market

lack of proper reimbursement for the orthodontic procedures and products due to limited insurance coverage is expected to hamper growth of dental braces market